DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 111 filers reported holding DICE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 11.16 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $365,018,194 | +62.2% | 7,856,612 | 0.0% | 6.89% | +35.2% |
| Q1 2023 | $225,091,934 | +5.3% | 7,856,612 | +14.7% | 5.10% | +17.6% |
| Q4 2022 | $213,686,023 | +102.3% | 6,848,911 | +31.5% | 4.33% | +92.3% |
| Q3 2022 | $105,637,000 | +30.7% | 5,208,911 | 0.0% | 2.25% | +4.6% |
| Q2 2022 | $80,842,000 | -18.9% | 5,208,911 | 0.0% | 2.16% | -0.9% |
| Q1 2022 | $99,646,000 | -24.4% | 5,208,911 | 0.0% | 2.17% | -6.5% |
| Q4 2021 | $131,838,000 | -22.7% | 5,208,911 | 0.0% | 2.32% | -1.7% |
| Q3 2021 | $170,592,000 | – | 5,208,911 | – | 2.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 3,292,871 | $62,993,000 | 33.95% |
| Sands Capital Ventures, LLC | 3,148,970 | $60,240,000 | 12.58% |
| OUP Management Co., LLC | 536,693 | $10,267,000 | 7.82% |
| New Leaf Venture Partners, L.L.C. | 556,693 | $10,650,000 | 5.25% |
| Logos Global Management LP | 1,385,251 | $26,500,000 | 3.44% |
| Soleus Capital Management, L.P. | 983,994 | $18,824,000 | 2.43% |
| RA Capital Management | 5,208,911 | $99,646,000 | 2.17% |
| Deep Track Capital, LP | 1,250,000 | $23,913,000 | 1.53% |
| Samsara BioCapital, LLC | 228,466 | $4,371,000 | 1.10% |
| HighVista Strategies LLC | 48,960 | $937,000 | 0.60% |